Bhavnagri Veer

CIK 00018089801 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001808980

Recent Transactions

50 trades

Tax Payment
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-14$5.67/sh−23,628→ 556,049 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-02-13$6.85/sh−3,000→ 577,677 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-01-17$7.04/sh−3,000→ 580,677 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-12-15$7.53/sh−5,602→ 583,677 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-23+175,438→ 589,279 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2022-03-23+272,435→ 272,435 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-15$7.68/sh−8,849→ 413,841 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-09-15$2.27/sh+5,000→ 426,669 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-09-15−5,000→ 112,300 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-09-15$24.77/sh−5,000→ 421,669 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-08-16$2.27/sh+5,000→ 426,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-08-16−5,000→ 117,300 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-08-16$21.00/sh−5,000→ 421,353 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-07-15$21.55/sh−5,000→ 421,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-07-15$2.27/sh+5,000→ 426,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-07-15−5,000→ 122,300 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-06-15$2.27/sh+5,000→ 426,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-06-15−5,000→ 127,300 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-06-15$25.32/sh−5,000→ 421,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-05-18$2.27/sh+5,000→ 426,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-05-18−5,000→ 132,300 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-05-18$30.00/sh−5,000→ 421,353 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-05-17$28.30/sh−5,000→ 421,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-05-17$2.27/sh+5,000→ 426,353 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-05-17−5,000→ 137,300 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-04-15$2.27/sh+10,000→ 431,353 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-04-15$32.64/sh−606→ 421,353 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-04-15$32.01/sh−9,394→ 421,959 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-04-15−10,000→ 142,300 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-26+22,202→ 421,353 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-03-26+82,469→ 82,469 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-03-15−10,000→ 152,300 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-15$2.27/sh+10,000→ 415,774 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-15$37.79/sh−9,600→ 399,551 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-15$38.15/sh−400→ 399,151 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-03-15$38.16/sh−6,623→ 409,151 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-12-17−51,500→ 162,300 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-12-17$2.27/sh+51,500→ 405,402 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-06$2.27/sh+10,000→ 363,902 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-10-06−10,000→ 213,800 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-06$40.00/sh−10,000→ 353,902 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-01$2.27/sh+25,000→ 378,902 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-10-01+25,000→ 223,800 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-01$37.03/sh−7,985→ 354,702 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-01$36.21/sh−16,215→ 362,687 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-10-01$37.73/sh−800→ 353,902 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-09-01$35.89/sh−400→ 353,902 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-09-01$2.27/sh+25,000→ 378,902 total
Sale
Allogene Therapeutics, Inc.$ALLO
Common Stock
2020-09-01$35.35/sh−24,600→ 354,302 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2020-09-01−25,000→ 248,800 total

Companies

Allogene Therapeutics, Inc.
General Counsel
$ALLO

Recent Filings

Address

210 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov